Lowering of plasma triglycerides as a result of decreased free fatty acid mobilization

Abstract
3, 5-Dimethylpyrazole and its metabolite 3-carboxy-5-methylpyrazole lower plasma FFA and decrease the level of plasma triglycerides. The metabolite given intravenously is more rapidly effective than 3, 5-dimethylpyrazole. Plasma cholesterol and phospholipids as well as blood glucose were not affected by these acute treatments.